A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease
- PMID: 36088095
- PMCID: PMC9449304
- DOI: 10.1016/j.chest.2022.03.052
A Man With Malaise, Myalgia, and Rapidly Progressive Interstitial Lung Disease
Abstract
A 45-year-old man sought treatment at the ED during the third wave of the COVID-19 pandemic with a month-long history of fatigue, cough, myalgia, and hand stiffness. He did not report dyspnea. He had no past medical history and previously was fit and active, working as a farmer. He was a lifelong nonsmoker and had no family history of lung disease.
Copyright © 2022 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures





References
-
- Sato S., Hirakata M., Kuwana M., et al. Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum. 2005;52(5):1571–1576. - PubMed
-
- Szodoray P., Hajas A., Kardos L., et al. Distinct phenotypes in mixed connective tissue disease: subgroups and survival. Lupus. 2012;21:1412–1422. - PubMed
-
- Sato S., Kuwana M., Fujita T., Suzuki Y. Anti-CADM-140/MDA5 autoantibody titer correlates with disease activity and predicts disease outcome in patients with dermatomyositis and rapidly progressive interstitial lung disease. Mod Rheumatol. 2013;23(3):496–502. - PubMed
-
- Ceribelli A., Fredi M., Taraborelli M., et al. Prevalence and clinical significance of anti-MDA5 antibodies in European patients with polymyositis/dermatomyositis. Clin Exp Rheumatol. 2014;32(6):891–897. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous